HOME >> BIOLOGY >> NEWS
Cloning reverses aging in cow cells, a milestone in medical research

agriculture," said Cristofalo, who, in addition to leading the Lankenau Institute for Medical Research, is also a professor of pathology, anatomy and cell biology at Jefferson Medical College of Thomas Jefferson University in Philadelphia. He is internationally recognized for his research on the molecular mechanisms of cellular aging.

His work is based on findings that suggest that cellular aging is characterized by differential gene expression. Furthermore, Cristofalo's studies also show that the inability of senescent cells to synthesize DNA in response to growth factors (and thus divide again) is partially based on impaired signaling pathways between the sensing sites at the cell membrane and the targets in the nucleus.

Francis is an associate investigator at the Lankenau Institute for Medical Research and often collaborates with Cristofalo. Her research examines the mechanism of action of a particular protein that declines during cellular aging. She focuses on the role that the loss of this protein has in the development of diseases that afflict the elderly, such as tumor formation, wound-healing and chronic skin conditions. Francis is also an assistant professor of pathology, anatomy and cell biology at Jefferson Medical College.

The Lankenau Institute for Medical Research is a subsidiary of Main Line Health. It is located on the campus of Lankenau Hospital, located in suburban Philadelphia, in a state-of-the-art building where investigators concentrate on molecular, cellular and developmental biology specific to cancer, atherosclerosis, heart disease, osteoporosis, Alzheimer's disease and other diseases of aging.

"The theme of aging and the diseases of aging is a rare focus for a research center. Our ultimate goal is to determine the basis for the vulnerability to these diseases as we age, and to help people stay independent and productive during their lives, while reducing the impact of age-related diseases," said Cristofalo.


'"/>

Contact: Laura Feragen
laura@toplin.com
215-886-4644
Thomas Jefferson University
25-Apr-2000


Page: 1 2

Related biology news :

1. Cloning pigs and drug discovery among hot topics
2. Cloning chip
3. Cloning primates is turning out to be a real challenge
4. Cloning can turn back the developmental clock
5. Cloning reverses aging in cow cells, Scienceauthors say
6. First Reproducible Cloning Of Mammals From Adult Cells Reported In Nature
7. Human Cloning: Grappling With Reality Penn Bioethicist To Explore The Facts Behind The Hysteria
8. The Cloning of Humans On The Adoption Model: Penn Bioethicist Will Present A Model For Future Laws Involving Human Cloning
9. UNESCO Director-General Reaffirms That Human Cloning Is Contrary To Human Dignity
10. Human Cloning: International Bioethics Committee President Stresses Political And Moral Commitment
11. Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cloning reverses aging cow cells milestone medical research

(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global leader ... series of digital telemetry implants to meet the ... part of the PhysioTel™ Digital platform, was designed ... data when incorporating functional endpoints into repeat-dose toxicology ...
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE San Diego ... provides the connective tissue that enhances care coordination among social ... client-level information; earned a second $1 million grant from the ... in community and; will be recognized as a "Live Well ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
(Date:1/22/2015)... January 22, 2015 Pipette.com has added ... to their comprehensive portfolio of Eppendorf products. , The ... purchase a Centrifuge 5424/5424 R and receive the following:, ... Eppendorf Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with proven ... for drug discovery to commercial manufacturing, announced today all ... Sequencing (NGS) data packages. The NGS analysis of ... the integrity of the gene, validation of the left ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: